Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RECAMO (Regional Centre for Applied Molecular Oncology) is a specialized research and diagnostic center based within the Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic. Established in 2010 with significant support from the European Regional Development Fund, the center focuses on translational oncology research to improve cancer diagnosis and treatment. Its core activities include the identification of novel biomarkers, the study of molecular mechanisms of resistance to therapy, and the development of personalized medicine strategies. RECAMO operates state-of-the-art laboratories for genomics, proteomics, and cell biology, serving as a hub for collaboration between academic researchers and clinical oncologists. The center provides advanced molecular diagnostic services that are directly integrated into the clinical care provided at the Masaryk Memorial Cancer Institute.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RECAMO.